Russia supplies Covid-19 vaccine to Belarus for clinical trials

FILE PHOTO: A nurse prepares Russia’s “Sputnik-V” vaccine against the coronavirus disease (COVID-19) for inoculation in a post-registration trials stage at a clinic in Moscow

MOSCOW (Reuters) – Russia has sent a first batch of its Sputnik V COVID-19 vaccine to Belarus for clinical trials, the first such delivery of the jab abroad, Russian sovereign wealth fund RDIF said on Monday.

Volunteers in Belarus would begin receiving the Russian vaccine from Oct. 1, the Russian Direct Investment Fund which is backing the vaccine developer, said.

(Reporting by Maria Kiselyova and Polina Ivanova; writing by Tom Balmforth; Editing by Alex Richardson)